CDKN3 and metastatic malignant neoplasm in the lymph nodes: Additionally, CDKN3 expression was associated with lymph node metastases in HNSC, KIRC, KIRP, LUAD, LUSC, and PRAD (Additional file 1: Fig. 3I–N).